149 related articles for article (PubMed ID: 22902480)
1. The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence.
Thormann N; Van de Walle GR; Azab W; Osterrieder N
Virus Res; 2012 Oct; 169(1):203-11. PubMed ID: 22902480
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
von Einem J; Smith PM; Van de Walle GR; O'Callaghan DJ; Osterrieder N
Virology; 2007 May; 362(1):151-62. PubMed ID: 17250864
[TBL] [Abstract][Full Text] [Related]
3. Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo.
Van de Walle GR; May ML; Sukhumavasi W; von Einem J; Osterrieder N
J Immunol; 2007 Sep; 179(6):4161-9. PubMed ID: 17785855
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
Osterrieder N; Van de Walle GR
Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
[TBL] [Abstract][Full Text] [Related]
5. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
[TBL] [Abstract][Full Text] [Related]
6. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N
Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444
[TBL] [Abstract][Full Text] [Related]
7. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].
Neubauer A; Meindl A; Osterrieder N
Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):351-4. PubMed ID: 10507185
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
[TBL] [Abstract][Full Text] [Related]
9. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence.
Osterrieder N; Neubauer A; Brandmüller C; Kaaden OR; O'Callaghan DJ
Virology; 1996 Dec; 226(2):243-51. PubMed ID: 8955044
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of EHV-4 gG-deleted mutant.
Azab W; El-Sheikh A; Abdel-Gawad A
Virus Genes; 2012 Feb; 44(1):109-11. PubMed ID: 21960433
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein G deletion mutants of equine herpesvirus 1 (EHV1; equine abortion virus) and EHV4 (equine rhinopneumonitis virus).
Huang J; Hartley CA; Ficorilli NP; Crabb BS; Studdert MJ
Arch Virol; 2005 Dec; 150(12):2583-92. PubMed ID: 16052277
[TBL] [Abstract][Full Text] [Related]
12. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.
von Einem J; Wellington J; Whalley JM; Osterrieder K; O'Callaghan DJ; Osterrieder N
J Virol; 2004 Mar; 78(6):3003-13. PubMed ID: 14990719
[TBL] [Abstract][Full Text] [Related]
13. Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model.
Spiesschaert B; Goldenbogen B; Taferner S; Schade M; Mahmoud M; Klipp E; Osterrieder N; Azab W
J Virol; 2015 Dec; 89(23):11899-908. PubMed ID: 26378176
[TBL] [Abstract][Full Text] [Related]
14. Expression of late viral proteins is restricted in nasal mucosal leucocytes but not in epithelial cells during early-stage equine herpes virus-1 infection.
Gryspeerdt AC; Vandekerckhove AP; Baghi HB; Van de Walle GR; Nauwynck HJ
Vet J; 2012 Aug; 193(2):576-8. PubMed ID: 22425309
[TBL] [Abstract][Full Text] [Related]
15. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
16. Equid herpesvirus type 3 infection produces membrane-associated and secreted forms of glycoprotein G that are not required for efficient cell-to-cell spread of the virus in vitro.
Losinno A; Vissani MA; Sanchez D; Damiani AM
Arch Virol; 2023 Mar; 168(4):122. PubMed ID: 36977931
[TBL] [Abstract][Full Text] [Related]
17. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.
Smith PM; Kahan SM; Rorex CB; von Einem J; Osterrieder N; O'Callaghan DJ
J Virol; 2005 Apr; 79(8):5105-15. PubMed ID: 15795295
[TBL] [Abstract][Full Text] [Related]
18. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM
Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124
[TBL] [Abstract][Full Text] [Related]
19. Identification of another B-cell epitope in the type-specific region of equine herpesvirus 4 glycoprotein G.
Maeda K; Mizukoshi F; Hamano M; Kai K; Kondo T; Matsumura T
Clin Diagn Lab Immunol; 2005 Jan; 12(1):122-4. PubMed ID: 15642995
[TBL] [Abstract][Full Text] [Related]
20. Meningoencephalitis in mice infected with an equine herpesvirus 1 strain KyA recombinant expressing glycoprotein I and glycoprotein E.
Frampton AR; Smith PM; Zhang Y; Grafton WD; Matsumura T; Osterrieder N; O'Callaghan DJ
Virus Genes; 2004 Aug; 29(1):9-17. PubMed ID: 15215680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
